Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases
type: MedicalStudy
description: Seamless Phase II-Phase III Randomized Clinical Trial to Identify and Confirm the Most Promising Novel Intervention to Alleviate Morbidity and Mortality After Allogeneic Hematopoietic Cell Transplantation Among Older, Medically Infirm, or Frail Patients With Hematological Diseases
status: TERMINATED
study design: INTERVENTIONAL
phase: PHASE2,PHASE3
start date: 2019-08-15
end date: 2025-12-31
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT03870750
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Fred Hutchinson Cancer Center
study subject: Hematopoietic and Lymphoid Cell Neoplasm
study subject: Non-Neoplastic Hematologic and Lymphocytic Disorder
keywords: PHASE2,PHASE3
keywords: INTERVENTIONAL
keywords: TERMINATED
keywords: Hematopoietic and Lymphoid Cell Neoplasm
keywords: Non-Neoplastic Hematologic and Lymphocytic Disorder

AI Analytics
type: Organization